Checked.be
Active
BE 0824.055.283Private limited company
Ferraz
Waversebaan 281 ·3001 Leuven, Belgium· 16 yrs active
Sector: Dental practice
(86230)
Conclusion
Ferraz has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €248k and a net result of €-3k. Equity remains stable across the filed fiscal years (±1.2% per year). Its solvency ranks better than 43% of 16012 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Based on the State Gazette, CBE and 5 annual accounts.
Key figures
| Equity | €248k |
| Net result | €-3k |
| Better than sector | 43% |
| Active | 16 yrs |
Financial profile
47
/ 100
Mixed profile: strong on stability, weaker on profitability.
All 5 axes are computed from data Checked has read.
Health
40
Profitability
0
Solvency
64
Growth
32
Stability
100
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
Established
Founded in 2010, 16 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
40
/ 100
Weak
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€10k
estimate, not credit advice
Score history
86
2021
86
2022
94
2023
86
2024
40
2025
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 0.35 (< 1.0)
-10
Quick ratio
Quick ratio 0.35 (< 0.6)
-5
Leverage
Debt/equity 0.81 (< 1.0)
+10
Profitability
Negatieve ROE -1%
-10
Interest coverage
Interest coverage 8.0× (≥ 3×)
+8
Profit trend
Net profit down YoY
-3
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview
Annual accounts filed on 08-06-2026 with the NBB · fiscal year 2025 · micro schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
declining
Net result: declining trend of ~17.7%/year over 5 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2025 · NACE 86, Human health activities · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 55.3% | 63.4% | |
| Net result | €-3k | €62k | |
| Equity | €248k | €132k | |
| Gross operating margin | €48k | €116k | |
| Total assets | €448k | €286k |
€34k
-44.8%
21-25
€-3k
-
21-25
€29k
-41.8%
21-25
€448k
+15.1%
21-25
€248k
-8.7%
21-25
€-104k
-
21-25
€782
-90.6%
21-25
€21k
+10.2%
21-25
€200k
+69.8%
21-25
€160k
+186.4%
21-25
€40k
-35.2%
21-25
0.35
-79.1%
21-25
0.35
-79.1%
21-25
55.3%
-20.7%
21-25
0.81
+86.0%
21-25
-1.1%
-
21-25
-0.6%
-
21-25
8.03
-59.5%
21-25
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - | - |
| EBITDA | €34k | €61k | €55k | €51k | €50k |
| Net profit | €-3k | €21k | €21k | €17k | €23k |
| Cash flow | €29k | €50k | €44k | €40k | €39k |
| Staff costs | - | - | - | - | - |
| Income taxes | €782 | €8k | €9k | €7k | €9k |
| Dividends | €21k | €19k | €14k | €2k | - |
| Total assets | €448k | €389k | €398k | €406k | €320k |
| Equity | €248k | €271k | €270k | €262k | €248k |
| Debt | €200k | €118k | €129k | €144k | €72k |
| of which ≤ 1y | €160k | €56k | €45k | €37k | €21k |
| of which > 1y | €40k | €62k | €84k | €105k | €51k |
| Working capital | €-104k | €38k | €65k | €58k | €101k |
| Employees (FTE) | - | - | - | - | - |
Ratios (computed)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Current ratio | 0.35 | 1.68 | 2.45 | 2.57 | 5.76 |
| Quick ratio | 0.35 | 1.68 | 2.45 | 2.57 | 5.76 |
| Working capital ratio | -23.3% | 9.8% | 16.3% | 14.3% | 31.6% |
| Solvency | 55.3% | 69.7% | 67.7% | 64.6% | 77.4% |
| Debt / equity | 0.81 | 0.43 | 0.48 | 0.55 | 0.29 |
| Long-term debt ratio | 0.16 | 0.23 | 0.31 | 0.40 | 0.21 |
| Interest coverage | 8.03 | 19.84 | 18.02 | 14.19 | 18.64 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| ROA | -0.6% | 5.3% | 5.3% | 4.1% | 7.2% |
| ROE | -1.1% | 7.7% | 7.8% | 6.3% | 9.3% |
| EBITDA margin | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - |
| Days inventory (DSI) | - | - | - | - | - |
Balance-sheet composition 2025
Full annual accounts (23 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Balance sheet, Assets | ||||||
| TOTAL ASSETS | 20/58 | €448k | €389k | €398k | €406k | €320k |
| Fixed assets | 21/28 | €392k | €295k | €289k | €311k | €198k |
| Tangible fixed assets | 22/27 | €392k | €295k | €289k | €311k | €198k |
| Current assets | 29/58 | €56k | €94k | €110k | €95k | €122k |
| Amounts receivable within one year | 40/41 | €7k | €2k | €34k | - | €195 |
| Cash & bank | 54/58 | €38k | €88k | €74k | €94k | €122k |
| Balance sheet, Equity & liabilities | ||||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €448k | €389k | €398k | €406k | €320k |
| Equity | 10/15 | €248k | €271k | €270k | €262k | €248k |
| Contributions / capital | 10/11 | €19k | €19k | €19k | €19k | €19k |
| Reserves | 13 | €229k | €253k | €251k | €244k | €229k |
| Accumulated profits (losses) | 14 | €0 | €0 | €0 | - | - |
| Amounts payable | 17/49 | €200k | €118k | €129k | €144k | €72k |
| Amounts payable after one year | 17 | €40k | €62k | €84k | €105k | €51k |
| Amounts payable within one year | 42/48 | €160k | €56k | €45k | €37k | €21k |
| Trade debts payable within one year | 44 | €30 | €30 | €314 | €1k | €1k |
| Income statement | ||||||
| Gross operating margin | 9900 | €48k | €63k | €57k | €64k | €53k |
| Operating result | 9901 | €2k | €32k | €32k | €27k | €35k |
| Financial income | 75 | €364 | €427 | €344 | €0 | - |
| Financial charges | 65 | €4k | €3k | €3k | €4k | €3k |
| Result before taxes | 9903 | €-2k | €29k | €30k | €23k | €32k |
| Income taxes | 67/77 | €782 | €8k | €9k | €7k | €9k |
| Net result for the period | 9904 | €-3k | €21k | €21k | €17k | €23k |
| Result to be appropriated | 9905 | €-3k | €21k | €21k | €17k | €23k |
Legal Structure
| NACE primary | Dental practice(86230) |
| Legal form | Private limited company(610) |
| Incorporation | 15-03-2010 |
| Status | Active |
| Postal code | 3001 |
Establishment units
's-Meiersstraat 11, 3000 Leuven
since 20102.186.426.817
Real-estate footprint
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24432H0066/00B012 | Flanders | 1,051 m² | 1 · 193 m² | 10.3 m · 2 fl. |
| 24502B0994/00K000 | Flanders | 326 m² | 1 · 178 m² | 12.9 m · 2 fl. |
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).
Updates
Next filing, fiscal year 2026, expected by
2026
08-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Weakest financial yearnet €-3k ▼113%
Net result drops to €-3k, the lowest in the series.
10-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
26-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
23-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
29-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
30-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
10-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
08-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
26-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
27-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
Dental practice86230Renting and operating of own or leased non-residential real estate, excluding land68203
Names & trade names
| Legal nameNL | Ferraz |
Similar companies
ANNE CORYN
BE 0808.154.114 · Watermaal-Bosvoorde
Vranckx Dental
BE 0843.022.743 · Ronse
SOCIETE DENTAIRE JAMILA GUERFALA
BE 1002.606.846 · Saint-Nicolas
Pieter DE BRUYCKERE
BE 0508.613.065 · Halle
PARS DENTAIRE
BE 0474.264.870 · Sint-Jans-Molenbeek